Digitisation | April 05, 2022
Feedback Medical brings Bleepa to India
Announces pilot project for rapid, remote diagnosis of tuberculosis
Announces pilot project for rapid, remote diagnosis of tuberculosis
Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024
Through this new set-up, the company intends to make available, affordable high-quality medical diagnostic imaging equipment across Tier 2, 3, and 4 towns in India
Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies
The plant is scheduled to come on stream in September 2024
The registry will be conducted for approximately two and a half years and up to 200 subjects will be enrolled
A novel second-generation approach to achieve a safe, durable, and stable transgene expression to overcome the challenges of factor VIII replacement therapies
It also empowers domestic precision immunotherapy for tumours and promotes the high-quality development of China's biopharmaceutical industry
A new course at the Azrieli Faculty of Medicine will focus on tissue regeneration and 3D printing for therapeutic needs
The collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules
Subscribe To Our Newsletter & Stay Updated
